ONBI OTC
ONE Bio Corp.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +150.0%
3Y: -90.0%
5Y: -98.2%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$52M
+136.9% ▲
5Y CAGR: +216.8%
Gross Profit
$20M
+101.6% ▲
5Y CAGR: +170.7%
Operating Income
$14M
+83.4% ▲
Net Income
$9M
+81.8% ▲
5Y CAGR: +246.6%
EPS (Diluted)
$1.35
+45.2% ▲
5Y CAGR: +40.1%
EBITDA
$14M
+69.6% ▲
5Y CAGR: +207.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 |
|---|---|---|---|---|---|
| Revenue | $208K | $579K | $78K | $22M | $52M |
| YoY Growth | +26.7% | +178.8% | -86.5% | +28112.2% | +136.9% |
| Cost of Revenue | $69K | $195K | $44K | $12M | $32M |
| Gross Profit | $139K | $384K | $34K | $10M | $20M |
| Gross Margin | 66.7% | 66.3% | 43.9% | 45.2% | 38.5% |
| R&D Expenses | $0 | $0 | $0 | $378K | $260K |
| SG&A Expenses | $130K | $334K | $59K | $2M | $6M |
| Operating Expenses | $150K | $341K | $69K | $3M | $6M |
| Operating Income | -$11K | $43K | -$34K | $7M | $14M |
| Operating Margin | -5.5% | 7.4% | -43.8% | 33.8% | 26.2% |
| Interest Expense | $5K | $8K | $8K | $230K | $736K |
| Income Before Tax | -$4K | $43K | -$42K | $7M | $12M |
| Tax Expense | $154 | $6K | $0 | $2M | $3M |
| Net Income | -$4K | $37K | -$42K | $5M | $9M |
| Net Margin | -1.8% | 6.4% | -53.9% | 21.6% | 16.6% |
| EPS (Diluted) | $-0.06 | $-0.01 | $-0.01 | $0.93 | $1.35 |
| EBITDA | $132K | -$4K | -$25K | $8M | $14M |
| Shares Outstanding | 66800 | 4M | 3M | 5M | 6M |